Otsuki T, Mori M, Tatibana M
J Biochem. 1981 May;89(5):1367-74.
Carbamoyl-phosphate synthetase II [EC 6.3.5.5] of rat ascites hepatoma cells (AH 13), the first and regulatory enzyme of de novo pyrimidine nucleotide biosynthesis, exists as a multienzyme complex (molecular weight, 870,000) with aspartate carbamoyltransferase [EC 2.1.3.2] and dihydroorotase [EC 3.5.2.3] (Mori, M. & Tatibana, M. (1975) J. Biochem. 78, 239-242). The purified complex was phosphorylated by the catalytic subunit of cAMP-dependent protein kinase [EC 2.7.1.37] of rabbit skeletal muscle. The incorporation of 32Pi was 2.2 mol/mol of the complex. The phosphorylation was completely inhibited by the inhibitor protein of the cAMP-dependent protein kinase. Among the substrates and effectors of the enzyme complex tested, only MgUTP, an allosteric inhibitor of carbamoyl-phosphate synthetase II, strongly inhibited the phosphorylation; this inhibition was due probably to the competition of MgUTP with y inhibited by the inhibitor protein of the cAMP-dependent protein kinase. Among the substrates and effectors of the enzyme complex tested, only MgUTP, an allosteric inhibitor of carbamoyl-phosphate synthetase II, strongly inhibited the phosphorylation; this inhibition was due probably to the competition of MgUTP with y inhibited by the inhibitor protein of the cAMP-dependent protein kinase. Among the substrates and effectors of the enzyme complex tested, only MgUTP, an allosteric inhibitor of carbamoyl-phosphate synthetase II, strongly inhibited the phosphorylation; this inhibition was due probably to the competition of MgUTP with the substrate MgATP for the protein kinase. The complex that was phosphorylated by cAMP-dependent protein kinase was dephosphorylated by phosphoprotein phosphatase [EC 3.1.3.16] of rat skeletal muscle. The complex was also phosphorylated by cAMP-independent protein kinase activity present in the extract of AH 13 cells and dephosphorylated by phosphoprotein phosphatase activity of the same origin. These results suggest that the complex is subject to phosphorylation and dephosphorylation in the living cells. Phosphorylation of the complex by cAMP-dependent protein kinase was associated only with a slight change, albeit definite, in the activity of carbamoyl-phosphate synthetase II under the assay conditions. Thus, the physiological significance of phosphorylation-dephosphorylation remains to be further studied.
大鼠腹水肝癌细胞(AH 13)中的氨甲酰磷酸合成酶II [EC 6.3.5.5]是从头嘧啶核苷酸生物合成的首个酶及调节酶,它以多酶复合物(分子量870,000)的形式存在,与天冬氨酸氨甲酰转移酶[EC 2.1.3.2]和二氢乳清酸酶[EC 3.5.2.3]结合在一起(森,M.和谷花,M.(1975年)《生物化学杂志》78, 239 - 242)。纯化后的复合物被兔骨骼肌的cAMP依赖性蛋白激酶[EC 2.7.1.37]的催化亚基磷酸化。32Pi的掺入量为每摩尔复合物2.2摩尔。磷酸化被cAMP依赖性蛋白激酶的抑制蛋白完全抑制。在所测试的酶复合物的底物和效应物中,只有氨甲酰磷酸合成酶II的变构抑制剂MgUTP强烈抑制磷酸化;这种抑制可能是由于MgUTP与底物MgATP竞争蛋白激酶所致。被cAMP依赖性蛋白激酶磷酸化后的复合物被大鼠骨骼肌的磷酸蛋白磷酸酶[EC 3.1.3.16]去磷酸化。该复合物也被AH 13细胞提取物中存在之不依赖cAMP的蛋白激酶活性磷酸化,并被同一来源的磷酸蛋白磷酸酶活性去磷酸化。这些结果表明该复合物在活细胞中会发生磷酸化和去磷酸化。在测定条件下,cAMP依赖性蛋白激酶对复合物的磷酸化仅伴随着氨甲酰磷酸合成酶II活性的轻微改变,尽管这种改变是确定的。因此,磷酸化 - 去磷酸化的生理意义仍有待进一步研究。